Clinical trials
Phase 1/2 Lymphoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| CytomX Therapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
| Sanofi | 1 |
| Therapeutic Advances in Childhood Leukemia Consortium | 1 |
| University of Aarhus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 11 |
| Leukemia | 4 |
| Hodgkin Disease | 2 |
| Immune System Diseases | 2 |
| Lymphatic Diseases | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Lymphoproliferative Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.